Prostate Cancer News Archive

Abiraterone for mCRPC May Benefit Blacks More Than Whites

Abiraterone for mCRPC May Benefit Blacks More Than Whites

Abiraterone plus prednisone was associated with significantly greater PSA progression-free survival among patients who are black compared with white patients.

Robotics Involved in Most Urologic Cancer Surgeries

Robotics Involved in Most Urologic Cancer Surgeries

In 2015, 69% of surgeries for prostate, bladder, and kidney cancer were performed with robotic assistance, a new meta-analysis shows.

Enzalutamide for Advanced Prostate Cancer Does Not Worsen HRQoL

Enzalutamide for Advanced Prostate Cancer Does Not Worsen HRQoL

Enzalutamide decreases the risk of clinically meaningful deterioration in HRQoL compared with placebo in men with non-metastatic CRPC, new study finds.

AUA Updates Castration-Resistant Prostate Cancer Clinical Guideline

AUA Updates Castration-Resistant Prostate Cancer Clinical Guideline

"We are confident this guideline is fully aligned with the latest science on treatments for patients with non-metastatic and metastatic CRPC," said Michael Cookson, MD, member of the 2018 amendment panel.

PSA Level 3 Months After Radiation Tx May Predict Outcome

PSA Level 3 Months After Radiation Tx May Predict Outcome

Findings for men with intermediate- and high-risk prostate cancer.

Current Smokers at Risk for Worse Prostate Cancer Outcomes

Current Smokers at Risk for Worse Prostate Cancer Outcomes

In a meta-analysis, smokers had an 89% greater risk of dying from prostate cancer compared with nonsmokers.

FDA Approves Yonsa for Metastatic Castration-Resistant Prostate Cancer

FDA Approves Yonsa for Metastatic Castration-Resistant Prostate Cancer

The approval of Yonsa was based on 2 randomized, placebo-controlled, multicenter Phase 3 studies in patients with mCRPC.

From 2008 to 2014, Prostate Cancer Testing, Treatment Down

From 2008 to 2014, Prostate Cancer Testing, Treatment Down

Sharpest decrease seen in privately insured men after 2011.

Laser Focal Ablation of Prostate Cancer Improves Outcomes

Laser Focal Ablation of Prostate Cancer Improves Outcomes

Men with low-risk PCa who underwent partial gland ablation with vascular-targeted photodynamic therapy were less likely than those on AS to require radical treatment.

Node-Positive Prostate Cancer on the Rise

Node-Positive Prostate Cancer on the Rise

The percentage of prostate cancer patients with positive lymph nodes increased from 2.4% in 2010 to 4.7% in 2014.

BPH, Cancers Linked to Peyronie's Disease

BPH, Cancers Linked to Peyronie's Disease

Men with Peyronie's disease have elevated risks of benign prostatic hyperplasia, prostatitis, and testis and prostate cancer, new studies reveal.

Testosterone Therapy Safe Despite Prostate Cancer History

Testosterone Therapy Safe Despite Prostate Cancer History

Findings from the largest study to date examining the effect of TRT in prostate cancer patients build on previous evidence showing that the treatment does not affect disease progression risk.

Incontinence, Impotence Risk After RP Linked to Metabolic Syndrome

Incontinence, Impotence Risk After RP Linked to Metabolic Syndrome

At 1 year post-op, patients with MetS prior to prostate surgery had a significantly lower continence rate than those without MetS (75.4% vs 82.6%).

Clinical Variables Predict Radiographic Progression in mCRPC

Clinical Variables Predict Radiographic Progression in mCRPC

Extent of disease and change in PSA were the strongest predictors of disease progression in men with chemotherapy-naïve mCRPC treated with abiraterone.

Focal vs Total PCa Cryoablation Better for Sexual Function

Focal vs Total PCa Cryoablation Better for Sexual Function

Oncologic outcomes are similar for focal and total cryoablation for localized prostate cancer, but patients report significantly better sexual function after focal cryoablation.

Negative Confirmatory Biopsy Predicts Lower PCa Progression Risk

Negative Confirmatory Biopsy Predicts Lower PCa Progression Risk

Men on active surveillance for prostate cancer who had a negative confirmatory biopsy experienced an 88% decreased risk of progression to treatment.

Prostate Cancer Recurrence Risk Lower With Anterior Tumors

Prostate Cancer Recurrence Risk Lower With Anterior Tumors

Following laparoscopic radical prostatectomy, men with posterior index tumors had 76% increased risk of biochemical recurrence vs those with anterior prostate tumors.

Gleason Score at Surgical Margin Affects BCR Risk

Gleason Score at Surgical Margin Affects BCR Risk

Gleason score at the margin can better stratify biochemical recurrence-free rates, according to study findings.

AS May Be Safe for Selected Men With Gleason 3+4 Prostate Cancer

AS May Be Safe for Selected Men With Gleason 3+4 Prostate Cancer

Men with Gleason 6 and Gleason 3+4 prostate cancer who undergo radical prostatectomy after a period on active surveillance have similar surgical outcomes.

Novel Blood Test Improves Detection of High-Grade Prostate Cancer

Novel Blood Test Improves Detection of High-Grade Prostate Cancer

IsoPSA can correctly rule out high-grade prostate cancer 93% of the time and thus has the potential to reduce the number of unnecessary prostate biopsies.

Optimal Post-Radical Prostatectomy Follow-up Schedule Proposed

Optimal Post-Radical Prostatectomy Follow-up Schedule Proposed

Investigators suggest PSA testing frequencies based on post-operative baseline PSA.

Overall, Drinking Wine Does Not Impact Prostate Cancer Risk

Overall, Drinking Wine Does Not Impact Prostate Cancer Risk

Findings show small increased risk with white wine, decreased risk with red wine

Predictors of Adverse Pathology After Prostate Cancer Surgery ID'd

Predictors of Adverse Pathology After Prostate Cancer Surgery ID'd

High PSA levels and larger number of positive biopsy cores are associated with positive surgical margins and extracapsular extension/seminal vesicle invasion after radical prostatectomy.

Smoking Ups Bladder Cancer Risk, Lowers Prostate Cancer Risk

Smoking Ups Bladder Cancer Risk, Lowers Prostate Cancer Risk

Men and women who smoke are at 2.3-fold and 2.7-fold increased risk of bladder cancer compared with non-smokers.

Cancer Incidences and Burden Expected to Shift in HIV-Positive

Cancer Incidences and Burden Expected to Shift in HIV-Positive

Prostate and lung cancer expected to emerge as the most common types by 2030.

USPSTF Updates Prostate Cancer Screening Recommendations

USPSTF Updates Prostate Cancer Screening Recommendations

The new statement emphasizes shared decision-making on screening for men aged 55 to 69 years who are at average risk for prostate cancer.

Surgical Overtreatment of Prostate Cancer May Be Decreasing

Surgical Overtreatment of Prostate Cancer May Be Decreasing

Canadian study shows that nearly all men undergoing radical prostatectomy in Eastern Ontario in recent years have clinically significant prostate cancer.

Gleason 4+3 vs 3+4 PCa Tied To Higher Risk of Metastasis at Diagnosis

Gleason 4+3 vs 3+4 PCa Tied To Higher Risk of Metastasis at Diagnosis

Men with Gleason score (GS) 4+3 prostate cancer have a 3-fold higher risk of distant metastasis at diagnosis than those with GS 3+4 PCa.

Obesity Linked to Lower Death Risk in Non-metastatic CRPC

Obesity Linked to Lower Death Risk in Non-metastatic CRPC

Obese men with non-metastatic castration-resistant prostate cancer have a 21% decreased risk of death compared with normal weight men, according to a study.

Cancer Screening More Likely After a Previous False Positive

Cancer Screening More Likely After a Previous False Positive

Findings for both men and women with a false-positive prostate or breast cancer test result.

BRCA Mutations Up Risk for PCa, Other Cancers

BRCA Mutations Up Risk for PCa, Other Cancers

Increased incidence of malignant disease, specifically prostate, melanoma, pancreas, breast cancers

Survey Highlights Emotional Responses to Prostate Cancer

Survey Highlights Emotional Responses to Prostate Cancer

Sexual dysfunction was a chief complaint among survey respondents with prostate cancer.

Myocarditis Rare Side Effect of Immune Checkpoint Inhibitors

Myocarditis Rare Side Effect of Immune Checkpoint Inhibitors

Myocarditis with ICIs may be more common than initially thought; responds to higher steroid dosages

Diet, Exercise With Behavioral Counseling Can Reduce ADT Side Effects

Diet, Exercise With Behavioral Counseling Can Reduce ADT Side Effects

A novel component of an interventional program was cognitive-behavioral counseling administered in a group setting to promote behavioral change.

Socioeconomics May Not Explain Racial Gap in Prostate Cancer Mortality

Socioeconomics May Not Explain Racial Gap in Prostate Cancer Mortality

In a study, race independently predicted prostate cancer-specific mortality beyond a number of risk factors, including health insurance status.

Low-Dose Abiraterone Noninferior for Castration-Resistant PCa

Low-Dose Abiraterone Noninferior for Castration-Resistant PCa

Low-dose AA with low-fat breakfast had greater effect on PSA; similar effect to standard dose

Adjuvant RT Plus ADT Beneficial in Selected Prostate Cancer Cases

Adjuvant RT Plus ADT Beneficial in Selected Prostate Cancer Cases

Study identifies which PCa patients with positive lymph nodes may have improved survival with the addition of adjuvant radiotherapy to androgen-deprivation therapy.

Biopsy-to-RP Delay May Up Prostate Cancer Recurrence Risk

Biopsy-to-RP Delay May Up Prostate Cancer Recurrence Risk

Researchers concluded that a greater than 90-day interval from prostate biopsy to radical prostatectomy increases the risk of biochemical recurrence among men with Gleason 3+4 disease.

Metastatic Prostate Cancer at Diagnosis in Decline

Metastatic Prostate Cancer at Diagnosis in Decline

Study documents a drop in the incidence of de novo metastatic PCa from 1980 to 2011 in the United States.

Finasteride Cuts Prostate Cancer Risk Long Term

Finasteride Cuts Prostate Cancer Risk Long Term

New study shows that men are at lower risk of prostate cancer for years after they stop taking the medication.

MRI Scans Can Avert Many Prostate Biopsies

MRI Scans Can Avert Many Prostate Biopsies

In a large international trial, pre-biopsy MRI scans spared 28% of men from having to undergo a biopsy and resulted in a lower detection of clinically insignificant cancers vs standard biopsy.

Dose-Escalated RT Does Not Improve Survival in Intermediate-Risk PCa

Dose-Escalated RT Does Not Improve Survival in Intermediate-Risk PCa

Researchers observed reductions in biochemical failure and distant metastasis rates in patients who had dose-escalated radiation therapy.

No Advantages With Aggressive Treatment in Metastatic Prostate Cancer

No Advantages With Aggressive Treatment in Metastatic Prostate Cancer

However, mortality higher with conservative therapy in locally advanced, non-metastatic prostate cancer.

Single PSA Screening Has No Effect on Prostate Cancer Mortality

Single PSA Screening Has No Effect on Prostate Cancer Mortality

Findings from a large study of men in the United Kingdom do not support single PSA testing for population-based screening.

EBRT+BT+ADT May Be Optimal for High-Grade PCa

EBRT+BT+ADT May Be Optimal for High-Grade PCa

In a study, extremely dose-escalated radiotherapy combined with androgen deprivation therapy offered the best cancer-specific survival among men with Gleason 9-10 prostate cancer.

Nocturia May Contribute to Sleep Problems in ADT Recipients

Nocturia May Contribute to Sleep Problems in ADT Recipients

In a 12-month study, men with prostate cancer treated with ADT reported more nocturia episodes than men with prostate cancer treated with prostatectomy alone and men with no history of cancer.

MRI May Help Cut Down on Unnecessary Prostate Biopsies

MRI May Help Cut Down on Unnecessary Prostate Biopsies

Multiparametic MRI findings added to conventional clinical predictors decreases the number of false-positive biopsy results without increasing the number of clinically significant tumors left undiagnosed, study finds.

FDA Oks Drug for Non-metastatic Castration-Resistant Prostate Cancer

FDA Oks Drug for Non-metastatic Castration-Resistant Prostate Cancer

Apalutamide prolonged metastasis-free survival by 2 years compared with placebo.

Upfront Docetaxel May Have Role in Advanced Prostate Cancer

Upfront Docetaxel May Have Role in Advanced Prostate Cancer

Added to hormone therapy, docetaxel offers a cost effective way to prolong hormone-sensitive disease and improve quality of life years, especially among men with non-metastatic disease, study finds.

Inclusion Criteria for PCa Trials Inadvertently Exclude Blacks

Inclusion Criteria for PCa Trials Inadvertently Exclude Blacks

Trials sponsored by academic investigators, cooperative groups more likely to use these criteria

Low-Carb Diet Tested as Way to Slow Recurrent Prostate Cancer

Low-Carb Diet Tested as Way to Slow Recurrent Prostate Cancer

In a small phase 2 study of overweight men with recurrent prostate cancer, consuming less than 20 grams of carbohydrates a day resulted in profound weight loss.

PSA Trajectory in nmCRPC Predicts Metastasis, Mortality Risk

PSA Trajectory in nmCRPC Predicts Metastasis, Mortality Risk

Metastasis and death are more likely to occur among patients with relatively high PSA levels at diagnosis of nmCRPC and rising PSA levels during follow-up.

Adverse Prostate Cancer Pathology Accurately Predicted With MRI

Adverse Prostate Cancer Pathology Accurately Predicted With MRI

Multiparametric MRI has high positive and negative predictive values for extracapsular extension, seminal vesicle invasion, lymph node involvement, and high-risk Gleason score.

Urologic Cancer Surgery Readmission Rate Highest for RC

Urologic Cancer Surgery Readmission Rate Highest for RC

In a study, nearly 20% of radical cystectomy patients were readmitted for complications within 90 days compared with 1.9% and 5.9% for radical prostatectomy and radical nephrectomy, respectively.

Early Prostate Cancer Salvage ADT Therapy Better

Early Prostate Cancer Salvage ADT Therapy Better

Among men who had PSA failure following radiation therapy for localized PCa, those with a long PSA doubling time had an increased risk of PCa mortality if they started androgen-deprivation therapy later.

Prostate Cancer Pathologic Features Worse in Blacks

Prostate Cancer Pathologic Features Worse in Blacks

Black men undergoing radical prostatectomy for prostate cancer are more likely to have indications for adjuvant radiotherapy compared with white men.

Statin Use May Improve Survival in Advanced Prostate Cancer

Statin Use May Improve Survival in Advanced Prostate Cancer

Statin use is associated with greater overall survival among men with metastatic castration-resistant prostate cancer and improved survival among patients with high-risk prostate cancer.

Negative Repeat Biopsy in PCa Active Surveillance a Positive Sign

Negative Repeat Biopsy in PCa Active Surveillance a Positive Sign

In a study, a negative confirmatory prostate biopsy in prostate cancer patients on active surveillance predicts a lower risk of progressing to treatment.

Earlier Prostate Cancer Drug Use in CRPC Cuts Metastasis Risk

Earlier Prostate Cancer Drug Use in CRPC Cuts Metastasis Risk

In separate studies, apalutamide and enzalutamide prolonged metastasis-free survival in men with non-metastatic castration-resistant prostate cancer.

Testosterone Therapy May Reduce PCa Risk in Hypogonadal Men

Testosterone Therapy May Reduce PCa Risk in Hypogonadal Men

In a study of hypogonadal men, those who received testosterone therapy had a lower incidence of prostate cancer than those who did not.

Telementoring Useful for Teaching Robotic Surgery

Telementoring Useful for Teaching Robotic Surgery

The technology facilitates teaching of advanced surgical skills, delivery of care to underserved

Brachytherapy Alone May Be Sufficient for More Risky PCa Cases

Brachytherapy Alone May Be Sufficient for More Risky PCa Cases

The investigators observed no difference in mortality between BT alone and BT plus ADT and/or EBRT supplemental therapy.

LDR Brachytherapy for Prostate Cancer Offers Excellent Survival

LDR Brachytherapy for Prostate Cancer Offers Excellent Survival

In a study, the 17-year prostate cancer-specific and biochemical failure-free survival rates were 97% and 79%, respectively.

Adjuvant Better Than Early Salvage RT for Some High-risk PCa Patients

Adjuvant Better Than Early Salvage RT for Some High-risk PCa Patients

Adjuvant radiotherapy was associated with lower risks for biochemical failure and distant metastases and increased overall survival in patients with adverse pathologic features found after radical prostatectomy.

Obesity, Metabolic Syndrome Increases Risk for PCa Recurrence

Obesity, Metabolic Syndrome Increases Risk for PCa Recurrence

Following radical prostatectomy, higher BMI increases risk of recurrence for prostate cancer.

Prostate Cancer ADT May Up Risk for Thromboembolism

Prostate Cancer ADT May Up Risk for Thromboembolism

Androgen-deprivation therapy without estrogen is associated with a significant 43% increased risk of thromboembolic events, meta-analysis shows.

Fosfomycin Tops Fluoroquinolones for Prostate Biopsy Prophylaxis

Fosfomycin Tops Fluoroquinolones for Prostate Biopsy Prophylaxis

In a meta-analysis, the risk of infectious complications was 78% lower with fosfomycin trometamol versus fluoroquinolones in men undergoing TRUS-guided prostate biopsy.

Routine Office Urine Culture Before Prostate Biopsy Is Unnecessary

Routine Office Urine Culture Before Prostate Biopsy Is Unnecessary

In a single center study, asymptomatic bacteriuria resolved before prostate biopsy, without additional treatment.

Polygenic Hazard Score Predicts Age of Prostate Cancer Diagnosis

Polygenic Hazard Score Predicts Age of Prostate Cancer Diagnosis

Polygenic hazard score can guide screening based off predicted prostate cancer diagnosis age.

PSA at 7 Months Prognostic in Treated mHSPC

PSA at 7 Months Prognostic in Treated mHSPC

A study showed longer survival among patients with metastatic hormone-sensitive prostate cancer who achieved a PSA level of 0.2 ng/mL or less 7 months after initiating ADT.

Mediterranean Diet Best for Lowering Aggressive Prostate Cancer Risk

Mediterranean Diet Best for Lowering Aggressive Prostate Cancer Risk

Study finds that closely adhering to a Mediterranean-style diet possibly protects men from aggressive and advanced prostate cancer.

High-grade Prostate Cancer Risk Again Linked to Cholesterol

High-grade Prostate Cancer Risk Again Linked to Cholesterol

Each 10 mg/dL increase in serum levels of total and HDL cholesterol are associated with a significant 5% and 14% increased risk of high-grade PCa, respectively.

Prostate Cancer Surgery Complications More Likely Among Older Men

Prostate Cancer Surgery Complications More Likely Among Older Men

Patient age 70 years and above is an independent risk factor for perioperative morbidity, according to data from a national cohort.

Odds of Prostate Cancer Treatment With SBRT Linked to Travel Distance

Odds of Prostate Cancer Treatment With SBRT Linked to Travel Distance

Patients who have to travel longer distances for prostate cancer treatment are more likely to receive stereotactic body radiotherapy.

Repeat Prostate Biopsies Do Not Raise Risk of Post-RP Complications

Repeat Prostate Biopsies Do Not Raise Risk of Post-RP Complications

Rates of erectile dysfunction and urinary incontinence at 1, 2, and 3 years after radical surgery are not higher among men who have multiple prostate biopsies while on active surveillance for prostate cancer.

Shift Workers at Higher Risk for Prostate Cancer

Shift Workers at Higher Risk for Prostate Cancer

A rotating shift schedule appeared the most risky.

Smaller Difference in Prostate Cancer Death Risk Found Between RT, RP

Smaller Difference in Prostate Cancer Death Risk Found Between RT, RP

Among patients with high-risk prostate cancer, investigators observe no significant difference in cancer-related death risk between radiotherapy and radical prostatectomy.

High Intakes of Teas, Peas, Soybeans May Increase Prostate Cancer Risk

High Intakes of Teas, Peas, Soybeans May Increase Prostate Cancer Risk

An analysis of an intervention arm of the PLCO Cancer Screening Trial evaluated the risk of prostate cancer relative to dietary consumption of isoflavones, a dietary compound found in some plant foods.

Enzalutamide Does Not Appear to Up Seizures in mCRPC

Enzalutamide Does Not Appear to Up Seizures in mCRPC

Male patients with mCRPC and seizure risk factors did not have increased seizure incidents when taking Enzalutamide.

Severe Acne May Boost Prostate Cancer Risk

Severe Acne May Boost Prostate Cancer Risk

Recent research suggests that P. acnes, which is associated with acne vulgaris, is more likely to be present in the prostatic tissue of patients with the disease than in healthy individuals.

MRI Predicts Outcomes of Prostate Cancer Salvage Radiotherapy

MRI Predicts Outcomes of Prostate Cancer Salvage Radiotherapy

A negative mpMRI is associated with a higher risk for PSA recurrence and metastasis following salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.

Cancer Pts With Private Insurance, Medicare May Have Survival Advantage

Cancer Pts With Private Insurance, Medicare May Have Survival Advantage

Cancer survival was greatly skewed toward patients with Medicare or private insurance.

Less Frequent Biopsies May Be Appropriate for PCa Active Surveillance

Less Frequent Biopsies May Be Appropriate for PCa Active Surveillance

Investigators who compared 4 active surveillance cohorts found that biennial prostate biopsies appear to be an acceptable alternative to annual biopsies.

Prostate Health Index Shown to Decrease Number of Prostate Biopsies

Prostate Health Index Shown to Decrease Number of Prostate Biopsies

Results of a large prospective study show that appropriate use of the phi test can improve physicians' ability to diagnose and manage patients.

PET/CT Imaging Phenotype Tied With Survival in mCRPC

PET/CT Imaging Phenotype Tied With Survival in mCRPC

Assessments of androgen receptor, glycolysis prognostic in castration-resistant prostate cancer.

Testosterone Therapy May Lower Prostate Cancer Incidence

Testosterone Therapy May Lower Prostate Cancer Incidence

Hypogonadal men who received testosterone replacement therapy had a lower incidence of prostate cancer than those who did not, and their cancers were less severe.

Second-Line Enzalutamide May Benefit Some mCRPC Patients

Second-Line Enzalutamide May Benefit Some mCRPC Patients

In a prospective study, mCRPC patients placed on enzalutamide after their disease progressed while on abiraterone therapy had a median radiographic progression-free survival of 8.1 months.

Active Surveillance Required After Prostate Cancer Focal Ablation

Active Surveillance Required After Prostate Cancer Focal Ablation

In a small but meaningful number of patients, Gleason pattern 4 disease missed by MRI and systematic biopsy is present outside the focal ablation zone.

Genetic Variant Predicts Faster Time to Prostate Cancer Metastasis

Genetic Variant Predicts Faster Time to Prostate Cancer Metastasis

The variant HSD3B1 allele increases the likelihood of metastasis in men receiving androgen-deprivation therapy for biochemically recurrent disease after radiotherapy for localized PCa.

Men With PCa Most Likely to Die From Other Causes

Men With PCa Most Likely to Die From Other Causes

Non-metastatic prostate cancer patients are more likely to die from causes other than the disease.

Prostate Cancer Hormone Therapy Ups Cardiac Risks

Prostate Cancer Hormone Therapy Ups Cardiac Risks

Exposure to androgen-deprivation therapy was associated with a nearly 2-fold increased risk of heart failure among men without pre-existing cardiovascular disease.

Clinicians Embrace New Prostate Cancer Grading System

Clinicians Embrace New Prostate Cancer Grading System

Endorsed by the International Society of Urological Pathology in 2014, the 5-tier Gleason grade group system is used routinely today in pathology reports and physician counseling of patients with newly diagnosed prostate cancer.

Brachytherapy + EBRT for High-Risk PCa Offers 'Excellent' Outcomes

Brachytherapy + EBRT for High-Risk PCa Offers 'Excellent' Outcomes

Biochemical failure and prostate cancer-specific mortality rates were 13.3% and 4.9% at 10 years, respectively.

Prostate Cancer Pathologic Stage Alone Independently Predicts BCRFS

Prostate Cancer Pathologic Stage Alone Independently Predicts BCRFS

Pathologic stages T3a and T3b versus T2a were associated with 8.45 and 7.1 times increased risk of biochemical recurrence on multivariable analysis.

Testosterone Patterns Predict Prostate Cancer Risk

Testosterone Patterns Predict Prostate Cancer Risk

The later a man's testosterone level dropped below 12.1 nmol/L, the lower his lifetime risk for prostate cancer.

BRCA2 Mutations Tied With Poor Survival, Progression in mCRPC

BRCA2 Mutations Tied With Poor Survival, Progression in mCRPC

Researchers find BRCA2 mutations are associated with worse outcomes among men with mCRPC.

IMRT for Prostate Cancer Radiation Therapy Soars

IMRT for Prostate Cancer Radiation Therapy Soars

Use of intensity-modulated radiation therapy for prostate cancer increased from 3.5% to 64% from 2002 to 2012.

Prostate Cancer Risk Lower in NSAID Users

Prostate Cancer Risk Lower in NSAID Users

In a case-control study, men who had ever used non-steroid anti-inflammatory drugs had a 23% decreased risk of prostate cancer.

Prostate Cancer Active Surveillance Use Low, But Increasing

Prostate Cancer Active Surveillance Use Low, But Increasing

Use of active surveillance for very low-risk prostate cancer rose from 11.6% of patients in 2010 to 27.3% in 2013, study finds.

First Metastasis Site Predicts Prostate Cancer-Specific Survival

First Metastasis Site Predicts Prostate Cancer-Specific Survival

Following curative treatment for localized PCa, 5-year PCa-specific survival rates are higher for patients with initial lymph node or locoregional metastases versus initial metastases in bone only or in multiple sites.

Sign Up for Free e-newsletters